Fless G M, Rolih C A, Scanu A M
J Biol Chem. 1984 Sep 25;259(18):11470-8.
Lipoprotein (a) (Lp(a] from the plasma of normolipidemic human donors was isolated by rate zonal and isopycnic density gradient ultracentrifugation. The final preparations usually contained varying amounts of isopycnic low-density lipoproteins (LDL), which were totally removed either by heparin-Sepharose column chromatography or by chromatofocusing. The Lp(a) preparations exhibited both inter- and intraindividual density heterogeneity which was accounted for by the differences in their protein and lipid composition. In addition, there was heterogeneity in the size of apoprotein (a) (apo(a] which was found to be linked to apoprotein B (apo-B) through disulfide bonds. Three different apo(a) species were obtained; they had a size either smaller, equal to, or larger than apo-B-100, the protein moiety of LDL. The apo(a) that was smaller than apo-B resided in a low-density Lp(a) particle whose peak was in the 1.019-1.063 g/ml density range. The larger apo(a) was a component of the dense Lp(a) particle and was responsible for the increased density in this Lp(a) species. The third apo(a) which was equivalent in size to apo-B resided in a density range intermediate between the other two Lp(a)s. It is concluded that Lp(a) may differ not only from one individual to another, but also within the same individual who may have more than one Lp(a) species. Part of this heterogeneity may be accounted for by differences in the (a) polypeptide.
通过速率区带离心和等密度梯度超速离心法,从血脂正常的人类供体血浆中分离出脂蛋白(a)[Lp(a)]。最终制备物通常含有不同量的等密度低密度脂蛋白(LDL),可通过肝素-琼脂糖柱色谱法或色谱聚焦法将其完全去除。Lp(a)制剂表现出个体间和个体内的密度异质性,这是由其蛋白质和脂质组成的差异所致。此外,载脂蛋白(a)[apo(a)]的大小存在异质性,发现其通过二硫键与载脂蛋白B(apo-B)相连。获得了三种不同的apo(a)种类;它们的大小要么小于、等于要么大于LDL的蛋白质部分apo-B-100。小于apo-B的apo(a)存在于低密度Lp(a)颗粒中,其峰值密度在1.019-1.063 g/ml范围内。较大的apo(a)是致密Lp(a)颗粒的一个组成部分,是该Lp(a)种类密度增加的原因。第三种大小与apo-B相当的apo(a)存在于另外两种Lp(a)之间的密度范围内。结论是,Lp(a)不仅在个体之间可能不同,而且在同一个体内也可能不同,同一个体可能有不止一种Lp(a)种类。这种异质性的部分原因可能是(a)多肽的差异。